Investigation of optimization of nanonized lipid carrier of drugs for enhanced transdermal delivery

博士 === 高雄醫學大學 === 藥學研究所 === 101 === Transdermal delivery system had lots of potentials as a rout for new dosage development, such as noninvasive way, non-GI absorption, which can avoid the disadvantages caused by COX-1 inhibition or serotonin. The propose of this research is to develop a novel trans...

Full description

Bibliographic Details
Main Authors: Chi-Te Huang, 黃繼德
Other Authors: Yi-Hung Tsai
Format: Others
Language:zh-TW
Published: 2013
Online Access:http://ndltd.ncl.edu.tw/handle/05113392974659693516
id ndltd-TW-101KMC05551026
record_format oai_dc
spelling ndltd-TW-101KMC055510262015-10-13T22:57:40Z http://ndltd.ncl.edu.tw/handle/05113392974659693516 Investigation of optimization of nanonized lipid carrier of drugs for enhanced transdermal delivery 奈米化脂質載體於經皮吸收促進之最佳化研究 Chi-Te Huang 黃繼德 博士 高雄醫學大學 藥學研究所 101 Transdermal delivery system had lots of potentials as a rout for new dosage development, such as noninvasive way, non-GI absorption, which can avoid the disadvantages caused by COX-1 inhibition or serotonin. The propose of this research is to develop a novel transdermal drug delivery system with microemulsion and evaluate physical and chemical properties such as Zeta potential, particle size, and in vitro transdermal delivery. Preliminary result has been found by experimental design. The flux and lag time of the meloxicam potassium and citalopram microemulsion formulation are (31.25 mg/cm2/h; 180.23 ng/cm2/h )and (2.84 h; 1.60h), is close to the values from real transdermal experiment (27.40 ±1.02; 179.63±20.44 mg/cm2/h) 和( 3 ±1; 1.67±0.58 h). For the animal study, the formulation revealed no irritation effect and cad easily reached the minimum effective concentration. It shows that its available to use experimental design for microemulsion formulation development for transdermal delivery system. Yi-Hung Tsai 蔡義弘 2013 學位論文 ; thesis 85 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 博士 === 高雄醫學大學 === 藥學研究所 === 101 === Transdermal delivery system had lots of potentials as a rout for new dosage development, such as noninvasive way, non-GI absorption, which can avoid the disadvantages caused by COX-1 inhibition or serotonin. The propose of this research is to develop a novel transdermal drug delivery system with microemulsion and evaluate physical and chemical properties such as Zeta potential, particle size, and in vitro transdermal delivery. Preliminary result has been found by experimental design. The flux and lag time of the meloxicam potassium and citalopram microemulsion formulation are (31.25 mg/cm2/h; 180.23 ng/cm2/h )and (2.84 h; 1.60h), is close to the values from real transdermal experiment (27.40 ±1.02; 179.63±20.44 mg/cm2/h) 和( 3 ±1; 1.67±0.58 h). For the animal study, the formulation revealed no irritation effect and cad easily reached the minimum effective concentration. It shows that its available to use experimental design for microemulsion formulation development for transdermal delivery system.
author2 Yi-Hung Tsai
author_facet Yi-Hung Tsai
Chi-Te Huang
黃繼德
author Chi-Te Huang
黃繼德
spellingShingle Chi-Te Huang
黃繼德
Investigation of optimization of nanonized lipid carrier of drugs for enhanced transdermal delivery
author_sort Chi-Te Huang
title Investigation of optimization of nanonized lipid carrier of drugs for enhanced transdermal delivery
title_short Investigation of optimization of nanonized lipid carrier of drugs for enhanced transdermal delivery
title_full Investigation of optimization of nanonized lipid carrier of drugs for enhanced transdermal delivery
title_fullStr Investigation of optimization of nanonized lipid carrier of drugs for enhanced transdermal delivery
title_full_unstemmed Investigation of optimization of nanonized lipid carrier of drugs for enhanced transdermal delivery
title_sort investigation of optimization of nanonized lipid carrier of drugs for enhanced transdermal delivery
publishDate 2013
url http://ndltd.ncl.edu.tw/handle/05113392974659693516
work_keys_str_mv AT chitehuang investigationofoptimizationofnanonizedlipidcarrierofdrugsforenhancedtransdermaldelivery
AT huángjìdé investigationofoptimizationofnanonizedlipidcarrierofdrugsforenhancedtransdermaldelivery
AT chitehuang nàimǐhuàzhīzhìzàitǐyújīngpíxīshōucùjìnzhīzuìjiāhuàyánjiū
AT huángjìdé nàimǐhuàzhīzhìzàitǐyújīngpíxīshōucùjìnzhīzuìjiāhuàyánjiū
_version_ 1718083233424343040